Chile vs Switzerland: Cause of death, by non-communicable diseases, ages 0-4
Chile
49.2%
in 2021
Switzerland
51.2%
in 2021
Chile rank
13th
Switzerland rank
10th
Cause of death, by non-communicable diseases, ages 0-4 over time
- Chile
- Switzerland
How they compare
Switzerland currently reports 51.2% against 49.2% in Chile, a difference of 2.0%.
Across all 6 years both countries report, Switzerland has been ahead every year.
Chile ranks 13th and Switzerland ranks 10th of 185 countries.
Switzerland has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Chile | Switzerland | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 43.0% | 48.1% | 5.1% | Switzerland |
| 2010s | 47.4% | 50.6% | 3.1% | Switzerland |
| 2020s | 49.1% | 51.4% | 2.3% | Switzerland |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 0-4, Chile or Switzerland?
- Switzerland, at 51.2% against 49.2% in Chile as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 0-4 between Chile and Switzerland?
- 2.0%, with Switzerland ahead.
- How many years of comparable data are there for Chile and Switzerland?
- 6 years are reported by both, from 2000 to 2021.
- How do Chile and Switzerland rank globally for cause of death, by non-communicable diseases, ages 0-4?
- Chile ranks 13th and Switzerland ranks 10th of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 0-4 (% of total deaths ages 0-4). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of deaths ages 0-4 due to non-communicable diseases divided by number of all deaths ages 0-4, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.